Interim Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Research and development, net	$ 2,060	$ 1,612	$ 4,646	$ 4,594
General and administrative, net	1,240	932	3,549	3,193
Operating loss	(3,300)	(2,544)	(8,195)	(7,787)
Financing income, net	85	98	144	201
Net loss	$ (3,215)	$ (2,446)	$ (8,051)	$ (7,586)
Basic net loss per share	$ (0.20)	$ (0.21)	$ (0.53)	$ (0.79)
Diluted net loss per share	$ (0.20)	$ (0.21)	$ (0.53)	$ (0.79)
Basic weighted average common shares outstanding	16,471,419	11,707,317	15,129,574	9,653,337
Diluted weighted average common shares outstanding	16,471,419	11,707,317	15,129,574	9,653,337